London UK; Philadelphia US; Geneva, Switzerland – July 20, 2018 — GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel…Original Article
FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
